Get startedLog in
    Picture of Theraclion SA logo

    ALTHE — Theraclion SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Theraclion announces FDA authorization to start US trial for immunotherapy and echotherapy combination on breast cancer

    Picture of Theraclion SA logoTheraclion SA
    26/06/2017 17:01
    June 26 (Reuters) - THERACLION SA  ALTHER.PA : 
    * THERACLION ANNOUNCES FDA AUTHORIZATION TO START U.S. TRIAL FOR IMMUNOTHERAPY AND 
ECHOTHERAPY COMBINATION ON BREAST CANCER 
 
Source text for Eikon:  ID:nBw5HQCvqa  
Further company coverage:  ALTHER.PA  
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Theraclion SA

    See all news